80%

of the logistics costs borne by pharmaceutical companies for shipping products under the cold chain are hidden costs.

20%

of pharmaceutical products are damaged during transport through a rupture in the cold chain.

35 billion

euros lost annually due to temperature excursions of medicines during transport.

Sofrigam has become one of the leading providers of insulated and refrigerated packaging solutions for the world's largest pharmaceutical and biotechnology companies. Our mission is not only to maintain perfectly stable temperatures throughout transport, but also to help our customers to optimize their supply chain in order to reduce their logistics costs and their environmental impact.

Configurator

Your privacy is our priority. Our site uses cookies for audience analysis purposes. You can accept or refuse the deposit of cookies.